GlassScriptPhysician profile
Rita A Christensen
NPI 1841308681
$1,754.87
in general payments reported to CMS, 2019-2025
20 companies · $15.40 in 2025
The $15.40 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $639 · 2022: $559 · 2023: $227 · 2024: $314 · 2025: $15.40.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $556.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $556.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $512.38 | 2022-2025 | Epclusa |
| Nevro Corp. | $456.55 | 2021-2022 | |
| Vanda Pharmaceuticals INC. | $110.81 | 2024 | Fanapt |
| Collegium Pharmaceutical, INC. | $101.68 | 2021-2022 | |
| Abbvie INC. | $77.96 | 2021-2022 | |
| Vertos Medical, INC. | $66.51 | 2022 | |
| Lilly USA, LLC | $64.03 | 2021-2022 | |
| Almatica Pharma LLC | $62.21 | 2022 | |
| Tersera Therapeutics LLC | $50.52 | 2021-2022 | |
| Biodelivery Sciences International, INC. | $45.34 | 2021 | |
| Ibsa Pharma INC. | $35.39 | 2021-2022 | |
| Indivior INC. | $34.09 | 2024 | Sublocade |
| Teva Pharmaceuticals USA, INC. | $24.26 | 2021 | |
| Braeburn INC. | $24.05 | 2024 | Brixadi |
| Zimmer Biomet Holdings, INC. | $18.47 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Therapeutics, INC. | $15.83 | 2021 | |
| Uswm, LLC | $15.17 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.87 | 2021 | |
| Boston Scientific Corporation | $13.01 | 2021 | |
| Abbott Laboratories | $12.74 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rita Christensen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.